Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models

相似書籍

• Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancers
  由: Mundt, Filip, et al.
  出版: (2018)
• PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer
  由: Rajput, Sandeep, et al.
  出版: (2019)
• Combined Targeting of mTOR and AKT is an Effective Strategy for Basal-like Breast Cancer in Patient-derived Xenograft Models
  由: Xu, Siguang, et al.
  出版: (2013)
• Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
  由: Rajput, Sandeep, et al.
  出版: (2016)
• Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
  由: Ma, Cynthia X., et al.
  出版: (2012)